Compare · ASH vs KVUE
ASH vs KVUE
Side-by-side comparison of Ashland Inc. (ASH) and Kenvue Inc. (KVUE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASH and KVUE operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- KVUE is the larger of the two at $37.13B, about 11.0x ASH ($3.38B).
- ASH has been more active in the news (10 items in the past 4 weeks vs 6 for KVUE).
- Both have 25 recent analyst ratings on file.
- Company
- Ashland Inc.
- Kenvue Inc.
- Price
- -
- -
- Market cap
- $3.38B
- $37.13B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NYSE
- NYSE
- IPO
- 2023
- News (4w)
- 10
- 6
- Recent ratings
- 25
- 25
Ashland Inc.
Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
Latest ASH
- Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
- Amendment: SEC Form SCHEDULE 13G/A filed by Ashland Inc.
- SVP, GC & Secretary Lampkin Robin E. exercised 1,806 shares at a strike of $74.58 and covered exercise/tax liability with 526 shares, increasing direct ownership by 26% to 6,299 units (SEC Form 4)
- Amendment: Ashland Inc. filed SEC Form 8-K: Leadership Update
- Ashland board authorizes quarterly dividend
- SEC Form 4 filed by Director Spizzo Allen A
- SEC Form 4 filed by Director Thomas Peter T
- SEC Form 3 filed by new insider Spizzo Allen A
- New insider Thomas Peter T claimed ownership of 4,500 shares (SEC Form 3)
- SEC Form SCHEDULE 13G filed by Ashland Inc.
Latest KVUE
- Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
- Amendment: SEC Form SCHEDULE 13G/A filed by Kenvue Inc.
- SEC Form 10-Q filed by Kenvue Inc.
- Kenvue Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Kenvue Reports Second Quarter 2026 Results
- Group President APAC Dasgupta Anindya converted options into 16,419 shares (SEC Form 4)
- Kenvue Increases Quarterly Cash Dividend
- Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
- SEC Form 4 filed by Director Smith Jeffrey C
- SEC Form 4 filed by Director Allison Richard E Jr